BSD Medical Corporation | Return to Homepage
Home    |    Contact us    |    Terms of Use    |    Privacy Statement    |    Site Map        
BSD Medical -- Delivering Thermal Energy to Medicine
About BSD Medical Products For Patients For Healthcare Professionals Investor Relations

Press Releases

  • 11/13/14 7:15 am MST
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a provider of medical systems that treat cancer and benign diseases using heat therapy, today reported financial results for its fiscal year ended August 31, 2014. Financial Highlights for Fiscal Year 2014 Total revenues of $5.3 million, a $1.6 million increase from $3.7 million for fiscal year 2013 Total stockholders’more...
  • 11/12/14 7:15 am MST
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that in connection with Mr. Carnell’s appointment, the Company and Mr. Carnell have agreed on an employment offer that provides in part that Mr. Carnell will be issued an inducement equity award outside the Company's Stock Incentive Plan in accordance with the NASDAQmore...
  • 11/10/14 6:30 am MST

    Brings Track Record of Proven Leadership and Commercial Success

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced that its Board of Directors has appointed Clint Carnell, 45, President, Chief Executive Officer, and member of the Board of Directors, effective immediately. Carnell succeeds Harold (Butch) R. Wolcott, who announced in April 2014 his intent to step down as CEO upon the hiring of a successormore...
  • 10/24/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that Drs. JY Gaubert, P Chevallier, and V Vidal, leading French researchers, presented the successful results of their animal study utilizing the MicroThermX® Microwave Ablation System (MicroThermX) at CIRSE 2014. The study was sponsored by Terumo Europe N.V. The objectivemore...
  • 10/15/14 7:15 am MDT

    Signs Distribution Agreement with KOL Bio-Medical Instruments, Inc.

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that the company has signed an agreement with KOL Bio-Medical Instruments, Inc. (KOL) for the sales and distribution of BSD’s MicroThermX® Microwave Ablation (MicroThermX) line of products. KOL sales and distribution area will include up to 15 states in the Northeast, Mid-more...
  • 9/29/14 7:15 am MDT

    Creates Sales Pathway for BSD-2000 in Largest and Most Receptive Hyperthermia End-Market in the World

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that BSD’s exclusive distributor in the People’s Republic of China, Dalian Orientech Co. LTD (“Orientech”), has informed BSD that China’s Food and Drug Administration (the “CFDA”) has approved and renewed the marketing and import license application for the BSD-2000more...
  • 9/25/14 7:15 am MDT

    German Joint Health Insurance Funds Reimburse Quality Controlled Pediatric Hyperthermia Treatments of Solid Tumors

    This is the Second German Center Established for the Treatment of Pediatric Tumors

    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that the Charité Universitätsmedizin Berlin (Charité), Department of Pediatric Hematology and Oncology, in cooperation with the Charité Department of Radiation Oncology, has opened a center dedicated to the treatment of pediatric tumors using hyperthermia and chemotherapy. Prof. Angelika Eggert MD, Chair of the Department of Pediatric Hematology and Oncology as wellmore...
  • 9/22/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) announced today that Terumo Europe NV (Terumo), a wholly owned subsidy of Terumo Corporation, successfully showcased BSD’s MicroThermX® Microwave Ablation System (MicroThermX) at the annual Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference, the world’s largest and most prestigious conference in the field of minimally invasive image-guided therapies. Terumomore...
  • 9/3/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, announced today that BSD has completed the sale of its fourth BSD-2000 Hyperthermia Systems (BSD-2000) ordered by its exclusive Taiwan distributor, Linden Bioscience Co., Ltd (Linden). Linden is a leading distributor of sophisticated medical devices in Taiwan. The Company hasmore...
  • 8/27/14 7:15 am MDT
    SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.BSDMedical.com), a leading provider of medical systems that treat cancer and benign diseases using heat therapy, today announced it will be featured as a presenting company at the 16th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co., LLC. The investor conference is being held September 8-10, 2014 at The Palace Hotel in New York Citymore...


Business Wire InvestorHQ℠